GM
Last reporting period 30 Jun, 2024
Updated 18 Sep, 2024
Last price
—
Market cap $B
16.818
Exchange
XCSE - Nasdaq Copenhagen A/S
1.5 B
Last period CFO ,DKK
719%
CFO has increased in 5 years
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also Genmab
Company Analysis
GMAB.CO valuation, rating, competitors, insights and company profile
Eyestock Rating
GMAB.CO financial analysis by Eyestock methodology
Valuation
GMAB.CO valuation using historical relative method
Statements
GMAB.CO Income Statements, Balance Sheet and Cash Flow Statements
Dividends
GMAB.CO dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
Genmab`s CFO for the period ended 2024-06-30 is 1.5 B DKK
